ArticleMedical oncology (Northwood, London, England)2026

Venetoclax combined with ML385 overcomes chemotherapy resistance in acute myeloid leukemia by modulating Nrf2/ARE-mediated oxidative stress.

Long Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.